Accrued and other current liabilities consist of the following:
September 30,
December 31,
2025
2024
Manufacturing and other research and development services
$
6,160
2,255
Clinical trial research and development services
3,087
1,236
General and administrative services
205
342
Compensation expense
6,764
8,315
Other
30
40
16,246
12,188
Accrued expenses and other current liabilities.
No definition available.